<DOC>
	<DOCNO>NCT01233830</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability pharmacokinetics AZD2423 young elderly healthy Japanese volunteer .</brief_summary>
	<brief_title>Study Investigate Safety , Tolerability Pharmacokinetics AZD2423 Multiple Doses Healthy Japanese Volunteers</brief_title>
	<detailed_description />
	<criteria>Provision sign date , write informed consent prior study specific procedure Healthy Japanese male volunteer age ≥20 ≤45 year healthy Japanese male female volunteer age ≥65 ≤80 year suitable vein cannulation repeat venipuncture Have body mass index ( BMI ) ≥17 ≤27 kg/m2 , calculate investigator ( ) , weigh least 45 kg 100 kg Clinically normal physical finding include supine blood pressure , pulse rate , ECG , laboratory assessment relation age , judge investigator ( ) History clinically significant disease disorder , opinion investigator ( ) , may either put volunteer risk participation study , influence result volunteer 's ability participate study History presence gastrointestinal , hepatic renal disease condition know interfere absorption , distribution , metabolism excretion drug Any clinically significant illness/infection medical/surgical procedure trauma , judge investigator ( ) , within 3 month first administration investigational product know malignancy within past 5 year ( exception successfully treat basal cell carcinoma )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>safety , tolerability , pharmacokinetics , AZD2423 , Japanese</keyword>
</DOC>